1. Home
  2. DTI vs MAIA Comparison

DTI vs MAIA Comparison

Compare DTI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Drilling Tools International Corporation

DTI

Drilling Tools International Corporation

SELL

Current Price

$1.97

Market Cap

88.6M

Sector

Industrials

ML Signal

SELL

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

SELL

Current Price

$1.19

Market Cap

79.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DTI
MAIA
Founded
1984
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.6M
79.0M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
DTI
MAIA
Price
$1.97
$1.19
Analyst Decision
Analyst Count
0
0
Target Price
$4.40
★ $12.00
AVG Volume (30 Days)
220.0K
★ 656.0K
Earning Date
11-05-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.33
EPS
★ N/A
N/A
Revenue
★ $154,446,000.00
N/A
Revenue This Year
$1.53
N/A
Revenue Next Year
$8.04
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1.59
N/A
52 Week Low
$1.87
$0.87
52 Week High
$4.69
$3.19

Technical Indicators

Market Signals
Indicator
DTI
MAIA
Relative Strength Index (RSI) 27.13 41.97
Support Level $1.87 N/A
Resistance Level $2.69 $1.47
Average True Range (ATR) 0.09 0.06
MACD -0.04 -0.00
Stochastic Oscillator 7.62 23.91

Price Performance

Historical Comparison
DTI
MAIA

About DTI Drilling Tools International Corporation

Drilling Tools International Corp is an oilfield services company that designs, engineers, and manufactures rental-focused tools used in onshore and offshore horizontal and directional drilling operations, as well as solutions across the well life cycle. It operates through two geographic segments: Western Hemisphere and Eastern Hemisphere. The Western Hemisphere, which generates the majority of revenue, provides downhole drilling tools and rental services for onshore and offshore operations across North America and Latin America, supported by service centers in the U.S. and Canada. The Eastern Hemisphere covers Europe, the Middle East, and Asia-Pacific, where the company offers drilling and well lifecycle solutions through international service centers across the EMEA and APAC regions.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: